David Lamond - Net Worth and Insider Trading
David Lamond Net Worth
The estimated net worth of David Lamond is at least $8 Million dollars as of 2024-12-27. David Lamond is the Director of Quince Therapeutics Inc and owns about 4,384,096 shares of Quince Therapeutics Inc (QNCX) stock worth over $8 Million. David Lamond is also the Director of Applied Molecular Transport Inc and owns about 1,077,519 shares of Applied Molecular Transport Inc (AMTI) stock worth over $283,387. Details can be seen in David Lamond's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Lamond has not made any transactions after 2023-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Lamond
David Lamond Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Lamond owns 3 companies in total, including Applied Molecular Transport Inc (AMTI) , Quince Therapeutics Inc (QNCX) , and Lucira Health Inc (LHDXQ) .
Click here to see the complete history of David Lamond’s form 4 insider trades.
Insider Ownership Summary of David Lamond
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AMTI | Applied Molecular Transport Inc | 2022-05-23 | director |
| QNCX | Quince Therapeutics Inc | 2023-12-14 | director |
| LHDXQ | Lucira Health Inc | 2021-02-04 | director |
David Lamond Latest Holdings Summary
David Lamond currently owns a total of 2 stocks. Among these stocks, David Lamond owns 4,384,096 shares of Quince Therapeutics Inc (QNCX) as of December 14, 2023, with a value of $8 Million and a weighting of 96.44%. David Lamond also owns 1,077,519 shares of Applied Molecular Transport Inc (AMTI) as of May 23, 2022, with a value of $283,387 and a weighting of 3.56%.
Latest Holdings of David Lamond
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2023-12-14 | 4,384,096 | 1.75 | 7,672,168 |
| AMTI | Applied Molecular Transport Inc | 2022-05-23 | 1,077,519 | 0.26 | 283,387 |
Holding Weightings of David Lamond
David Lamond Form 4 Trading Tracker
According to the SEC Form 4 filings, David Lamond has made a total of 9 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Quince Therapeutics Inc is the acquisition of 67,881 shares on December 14, 2023, which cost David Lamond around $69,239.
According to the SEC Form 4 filings, David Lamond has made a total of 2 transactions in Applied Molecular Transport Inc (AMTI) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Applied Molecular Transport Inc is the acquisition of 66,500 shares on May 23, 2022, which cost David Lamond around $210,805.
Insider Trading History of David Lamond
- 1
David Lamond Trading Performance
GuruFocus tracks the stock performance after each of David Lamond's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Lamond is 0.67%. GuruFocus also compares David Lamond's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Lamond within 3 months outperforms 5 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Lamond's insider trading performs compared to the benchmark.
Performance of David Lamond
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.72 | | | | | |
| Relative Return to S&P 500(%) | 1.55 | | | | | |
David Lamond Ownership Network
David Lamond Owned Company Details
What does Applied Molecular Transport Inc do?
Who are the key executives at Applied Molecular Transport Inc?
David Lamond is the director of Applied Molecular Transport Inc. Other key executives at Applied Molecular Transport Inc include Chief Financial Officer Shawn Cross , director & Chief Executive Officer Mahmood Tahir Ph.d. , and VP & Finance & Bus. Ops. Brandon Hants .
Applied Molecular Transport Inc (AMTI) Insider Trades Summary
Over the past 18 months, David Lamond made no insider transaction in Applied Molecular Transport Inc (AMTI). Other recent insider transactions involving Applied Molecular Transport Inc (AMTI) include a net sale of 400,768 shares made by Shawn Cross , a net sale of 222,101 shares made by Brandon Hants , and a net sale of 474,999 shares made by Mahmood Tahir Ph.d. .
In summary, during the past 3 months, insiders sold 0 shares of Applied Molecular Transport Inc (AMTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,097,868 shares of Applied Molecular Transport Inc (AMTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,097,868 shares.
Applied Molecular Transport Inc (AMTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Applied Molecular Transport Inc Insider Transactions
David Lamond Mailing Address
Above is the net worth, insider trading, and ownership report for David Lamond. You might contact David Lamond via mailing address: C/o Cortexyme, Inc., 269 East Grand Ave., South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
